PortfoliosLab logoPortfoliosLab logo
LABU vs. BNO
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

LABU vs. BNO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Direxion Daily S&P Biotech Bull 3x Shares (LABU) and United States Brent Oil Fund LP (BNO). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, LABU achieves a -0.77% return, which is significantly lower than BNO's 86.76% return. Over the past 10 years, LABU has underperformed BNO with an annualized return of -13.92%, while BNO has yielded a comparatively higher 13.38% annualized return.


LABU

1D
-12.94%
1M
-8.90%
YTD
-0.77%
6M
7.41%
1Y
193.25%
3Y*
6.21%
5Y*
-33.29%
10Y*
-13.92%

BNO

1D
0.76%
1M
-7.65%
YTD
86.76%
6M
83.45%
1Y
89.50%
3Y*
27.10%
5Y*
23.77%
10Y*
13.38%
*Multi-year figures are annualized to reflect compound growth (CAGR)

LABU vs. BNO - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
LABU
Direxion Daily S&P Biotech Bull 3x Shares
-0.77%79.17%-26.02%-13.41%-80.36%-64.15%74.66%75.50%-57.61%149.12%
BNO
United States Brent Oil Fund LP
86.76%-5.44%9.67%-3.43%35.25%62.34%-38.23%36.01%-15.30%15.43%

Correlation

The correlation between LABU and BNO is -0.29, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

-0.29

Correlation (3Y)
Calculated over the trailing 3-year period

-0.11

Correlation (5Y)
Calculated over the trailing 5-year period

-0.01

Correlation (10Y)
Calculated over the trailing 10-year period

0.10

Correlation (All Time)
Calculated using the full available price history since May 29, 2015

0.11

The correlation between LABU and BNO shifts across timeframes, from -0.29 (1 year) to 0.11 (all time), reflecting how their relationship changes across market environments.

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

LABU vs. BNO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

LABU
LABU Risk / Return Rank: 7676
Overall Rank
LABU Sharpe Ratio Rank: 7878
Sharpe Ratio Rank
LABU Sortino Ratio Rank: 6262
Sortino Ratio Rank
LABU Omega Ratio Rank: 5555
Omega Ratio Rank
LABU Calmar Ratio Rank: 9494
Calmar Ratio Rank
LABU Martin Ratio Rank: 9090
Martin Ratio Rank

BNO
BNO Risk / Return Rank: 6565
Overall Rank
BNO Sharpe Ratio Rank: 6464
Sharpe Ratio Rank
BNO Sortino Ratio Rank: 5656
Sortino Ratio Rank
BNO Omega Ratio Rank: 6060
Omega Ratio Rank
BNO Calmar Ratio Rank: 8989
Calmar Ratio Rank
BNO Martin Ratio Rank: 5757
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

LABU vs. BNO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Direxion Daily S&P Biotech Bull 3x Shares (LABU) and United States Brent Oil Fund LP (BNO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


LABUBNODifference

Sharpe ratio

Return per unit of total volatility

2.57

2.17

+0.39

Sortino ratio

Return per unit of downside risk

2.91

2.68

+0.23

Omega ratio

Gain probability vs. loss probability

1.34

1.37

-0.02

Calmar ratio

Return relative to maximum drawdown

7.09

5.39

+1.70

Martin ratio

Return relative to average drawdown

20.95

10.23

+10.72

LABU vs. BNO - Sharpe Ratio Comparison

The current LABU Sharpe Ratio is 2.57, which is comparable to the BNO Sharpe Ratio of 2.17. The chart below compares the historical Sharpe Ratios of LABU and BNO, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


LABUBNODifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

2.57

2.17

+0.39

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.35

0.68

-1.03

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

-0.15

0.37

-0.51

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.24

0.14

-0.38

Drawdowns

LABU vs. BNO - Drawdown Comparison

The maximum LABU drawdown since its inception was -99.18%, which is greater than BNO's maximum drawdown of -87.06%. Use the drawdown chart below to compare losses from any high point for LABU and BNO.


Loading charts...

Drawdown Indicators


LABUBNODifference

Max Drawdown

Largest peak-to-trough decline

-99.18%

-87.06%

-12.12%

Max Drawdown (1Y)

Largest decline over 1 year

-30.70%

-17.87%

-12.83%

Max Drawdown (3Y)

Largest decline over 3 years

-78.30%

-23.75%

-54.55%

Max Drawdown (5Y)

Largest decline over 5 years

-97.59%

-33.70%

-63.89%

Max Drawdown (10Y)

Largest decline over 10 years

-98.96%

-75.18%

-23.78%

Current Drawdown

Current decline from peak

-96.50%

-12.04%

-84.46%

Average Drawdown

Average peak-to-trough decline

-81.67%

-40.18%

-41.49%

Ulcer Index

Depth and duration of drawdowns from previous peaks

10.40%

9.43%

+0.97%

Volatility

LABU vs. BNO - Volatility Comparison

Direxion Daily S&P Biotech Bull 3x Shares (LABU) has a higher volatility of 28.40% compared to United States Brent Oil Fund LP (BNO) at 15.03%. This indicates that LABU's price experiences larger fluctuations and is considered to be riskier than BNO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


LABUBNODifference

Volatility (1M)

Calculated over the trailing 1-month period

28.40%

15.03%

+13.37%

Volatility (6M)

Calculated over the trailing 6-month period

60.11%

36.08%

+24.03%

Volatility (1Y)

Calculated over the trailing 1-year period

76.20%

41.56%

+34.64%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

95.56%

35.37%

+60.19%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

95.43%

36.68%

+58.75%

LABU vs. BNO - Expense Ratio Comparison

LABU has a 1.12% expense ratio, which is higher than BNO's 0.90% expense ratio.


Dividends

LABU vs. BNO - Dividend Comparison

LABU's dividend yield for the trailing twelve months is around 0.78%, while BNO has not paid dividends to shareholders.


PositionTTM202520242023202220212020201920182017
BNO
United States Brent Oil Fund LP
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
LABU
Direxion Daily S&P Biotech Bull 3x Shares
0.78%0.84%0.35%0.35%0.00%0.00%0.00%0.28%0.64%0.17%

Frequently Asked Questions


LABU and BNO have a correlation of -0.29, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

LABU has higher volatility (28.40%) compared to BNO (15.03%). In terms of maximum drawdown, LABU dropped -99.18% vs BNO's -87.06%.

On 10-year performance, BNO leads with 13.38% vs -13.92% for LABU. On fees, BNO is cheaper at 0.90% per year. On volatility, BNO has been the lower-risk option at 15.03%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 10-year period, BNO has performed better with a 13.38% return vs -13.92%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

BNO is cheaper with a 0.90% expense ratio, compared with 1.12% for LABU.

LABU has the higher dividend yield at 0.78%, compared with 0.00% for BNO.

LABU is categorized as Leveraged Equities, while BNO is Oil & Gas. LABU tracks S&P Biotechnology Select Industry Index (300%), while BNO tracks Front Month Brent Crude Oil. They also come from different issuers: Direxion and Concierge Technologies. Their fees differ too: 1.12% for LABU and 0.90% for BNO.

LABU currently has the higher Sharpe Ratio (2.57 vs 2.17), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for LABU and BNO

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer